🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Previously untreated CD20 positive diffuse large B-cell lymphoma (DLBCL) re...
Status
Completed
Location
Southampton University Hospitals NHS Tust
Start Date
2017-06-02
Trial ID
NCT03571308
Treatments Being Tested
Within this exploratory multicohort phase II trial, SAKK aims to evaluate a...
Status
Active Not Recruiting
Location
Ospedale Papa Giovanni XXIII
Start Date
2021-06-25
Trial ID
NCT04604067
Treatments Being Tested
The goal of this clinical trial is to study the addition of Acalabrutinib t...
Status
Recruiting
Location
Saarland University Medical Center
Start Date
2023-06-07
Trial ID
NCT05820841
Treatments Being Tested
Phase 3 randomized, double-blind, placebo-controlled, study assessing the e...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-10-08
Trial ID
NCT04529772
Treatments Being Tested
This is a multicenter, open-label, non-randomized, phase II clinical trial ...
Status
Active Not Recruiting
Location
BC Cancer Agency
Start Date
2021-03-01
Trial ID
NCT04566887
Treatments Being Tested
This study evaluates the addition of Acalabrutinib to current standard ther...
Status
Active Not Recruiting
Location
Colchester General Hospital
Start Date
2021-10-19
Trial ID
NCT04546620
Treatments Being Tested
The STELLAR trial will assess the effect of acalabrutinib taken in combinat...
Status
Active Not Recruiting
Location
Belfast City Hospital
Start Date
2019-07-23
Trial ID
NCT03899337
Treatments Being Tested
This is a single-arm, open-label, multicenter, non-indication seeking phase...
Status
Recruiting
Location
Research Site
Start Date
2025-09-05
Trial ID
NCT07029737
Background: Diffuse large B-cell lymphoma is the most common type of non-H...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2019-08-05
Trial ID
NCT04002947
Treatments Being Tested